BiomX Inc.
AMEX:PHGE
0.41 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | -0.357 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.803 | 0.871 | 2.52 | 2.565 | 2.18 | 0.318 | 0.21 | 0.095 |
| Gross Profit
| -1.803 | -1.228 | -2.654 | -2.565 | -2.18 | -0.405 | -0.21 | -0.095 |
| Gross Profit Ratio
| 0 | 3.44 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 24.663 | 19.035 | 16.244 | 22.676 | 20.935 | 13.489 | 9.571 | 4.741 |
| General & Administrative Expenses
| 11.776 | 8.65 | 9.456 | 11.267 | 9.323 | 8.718 | 3.36 | 0 |
| Selling & Marketing Expenses
| 0 | -0.871 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 11.776 | 7.779 | 9.456 | 11.267 | 9.323 | 8.718 | 3.36 | 2.536 |
| Other Expenses
| 0 | 0 | 1.519 | 1.519 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 36.439 | 26.814 | 25.7 | 33.943 | 30.258 | 22.207 | 12.931 | 7.277 |
| Operating Income
| -39.027 | -27.685 | -28.642 | -35.462 | -30.936 | -22.207 | -13.141 | -7.372 |
| Operating Income Ratio
| 0 | 77.549 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0 | 1.539 | 0.39 | -0.697 | 0.85 | 2.11 | 0.421 | 0.939 |
| Income Before Tax
| 17.727 | -26.146 | -28.252 | -36.159 | -30.086 | -20.563 | -12.72 | -6.433 |
| Income Before Tax Ratio
| 0 | 73.238 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.023 | 0.065 | 0.067 | -0.172 | -1.644 | 0.225 | 0 |
| Net Income
| 17.727 | -26.169 | -28.317 | -36.226 | -30.086 | -18.919 | -12.72 | -6.433 |
| Net Income Ratio
| 0 | 73.303 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 1.41 | -5.1 | -9.49 | -13.93 | -1.3 | -3.66 | -6.46 | -3.27 |
| EPS Diluted
| 1.35 | -5.1 | -9.49 | -13.93 | -1.3 | -3.66 | -6.46 | -3.27 |
| EBITDA
| -13.125 | -22.815 | -23.65 | -32.888 | -27.899 | -20.181 | -12.51 | -6.338 |
| EBITDA Ratio
| 0 | 63.908 | 0 | 0 | 0 | 0 | 0 | 0 |